HomeMNMD • NASDAQ
add
Mind Medicine (MindMed) Inc
Previous close
$6.70
Day range
$6.46 - $6.74
Year range
$5.05 - $12.22
Market cap
492.79M USD
Avg Volume
2.62M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 24.79M | 14.69% |
Net income | -13.68M | 23.65% |
Net profit margin | — | — |
Earnings per share | -0.18 | 71.00% |
EBITDA | -24.79M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 295.28M | 150.88% |
Total assets | 319.77M | 125.91% |
Total liabilities | 57.58M | 26.34% |
Total equity | 262.19M | — |
Shares outstanding | 73.33M | — |
Price to book | 2.09 | — |
Return on assets | -21.08% | — |
Return on capital | -24.17% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -13.68M | 23.65% |
Cash from operations | -17.19M | -3.40% |
Cash from investing | — | — |
Cash from financing | 69.35M | 298.63% |
Net change in cash | 52.15M | 6,386.57% |
Free cash flow | -20.27M | -67.82% |
About
Mind Medicine Inc., doing business as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
Founded
2010
Website
Employees
57
